NCT00012467 - Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2000

Study Completion Date

July 31, 2001

Conditions

Meningitis, CryptococcalHIV Infections

Interventions

DRUG

Itraconazole

DRUG

Flucytosine

DRUG

Fluconazole

DRUG

Amphotericin B

DRUG

Interferon gamma-1b

Trial Locations (9)

Univ of Alabama at Birmingham, Birmingham

Washington Univ, St Louis

Houston Veterans Administration Med Ctr, Houston

Univ of Texas / Med School at Houston, Houston

Audie L Murphy Veterans Administration Hosp, San Antonio

UMDNJ - New Jersey Med School / Cooper Hosp, Camden

Univ of Med & Dentistry of New Jersey, Newark

Hosp Nacional dos de Mayo, Lima

Instituto de Medicina Tropical, Lima